Sign in
4

Changes in Ownership

ARS Pharmaceuticals, Inc. Filed Acc 0000947871-24-000728

Director sold 83,695 shares at $13.00 ($1,088,035)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
ORBIMED ADVISORS LLC Director 2024-08-26 Sale −83,695 $13.00 $1,088,035 0 I
Open-market sales · 83,695 sh · avg $13.00 · $1,088,035
Loading xslF345X05/ownership.xml…